Dr Lalchand. Lab

{
  "main_header": {
    "sid": 1002986,
    "name": "Dr Lalchand. Lab",
    "stock_name": "Dr Lalchand. Lab",
    "full_name": "Dr Lalchandani Labs Ltd",
    "name_url": "stocks-analysis/dr-lalchand-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "7.25",
    "chg": -0.17,
    "chgp": "-2.29%",
    "dir": -1,
    "prev_price": "7.42",
    "mcapval": "6.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541299,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE871Z01013",
    "curr_date": "Sep 25, 03:30 PM",
    "curr_time": "18:03 PM",
    "last_traded_at": "Sep 25, 03:30 PM IST",
    "bse_nse_vol": 8000,
    "exc_status": "Active",
    "traded_date": "Sep 25, 2026",
    "traded_date_str": "2026 09 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-lalchand-lab-1002986-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 53,
    "sid": "1002986",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-lalchandani-labs-1002986"
  },
  "announcements": [
    {
      "caption": "Extension For Annual General Meeting For FY 2025-2026",
      "datetime": "17-Sep-2026",
      "details": "The company due to ill health of the Chairman of the Company had filed the Application for extension of Annual General Meeting (AGM) for FY 2025-26 the ROC Delhi has considered and approved the application and granted the extension for the period of 3 month i.e. December 31 2026. Therefore the Company will hold the AGM for FY 2025-26 at the earliest but not later than December 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "17-Jul-2026",
      "details": "Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations for quarter ended June 2026",
      "source": "BSE"
    },
    {
      "caption": "Approval Of Audited Financial Results For The Half Year And Year Ended March 31 2026",
      "datetime": "03-Jun-2026",
      "details": "Audited Financial Results for the half year and year ended March 31 2206",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Lalchandani Labs Ltd has announced <strong>1:1</strong> rights issue, ex-date: 27 Jan 26",
          "dt": "2026-01-27",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

No Recent News for the Company

View All News